Careers @ Myeloid
Want to be part of a team that's making big strides in solving big human health problems? Consider reaching out to see if we're a good fit.
Myeloid Kind of People
"Discovery consists of looking at the same thing as everyone else and thinking something different"
- Albert Szent-Gyorgyi
Passion
for scientific inquiry and dedication to solving big problems
Selfless &
relentless collaboration
Creativity &
flexibility in the face of challenges
Accountability &
a commitment to excellence
Working inter-professionally/personally to create meaningful human health solutions
DISCOVERY
RESEARCH
Yuxiao Wang, PhD
Kyong-Rim Kieffer-Kwon, PhD
Neha Diwanji, PhD
Ece Bapcum
Charlotte Pratt
Ty Chu, PhD
IMMUNOLOGY BIOPROCESS
& DEVELOPMENT
Patrick Tavares
Jodie D’Alessandro
MOLECULAR &
RNA SCIENCES
Inna Shcherbakova, PhD
Tyler Nicholson
Marie Didiot, PhD
Bill Rowley
CMC &
MANUFACTURING
Caitlyn Harvey
James Collins
TRANSLATIONAL IMMUNOLOGY
Thomas Prod'homme, PhD
Chetan Rane, PhD
Amritha Ramakrishnan, PhD
CLINICAL DEVELOPMENT & OPERATIONS
Sophia Mansora
Hannah Crowell
Tommy Chang
Myeloid Therapeutics is an immunology company focused on combining biology insights with cutting-edge technologies to harness myeloid cells and eradicate cancer and other diseases. With broad clinical applications possible, the Company is presently advancing its cell therapy product candidates, derived from its ATAKTM platform technology, with initial applications in T cell lymphoma and a primed monocyte approach to treating glioblastoma. The ATAK platform is scalable to multiple treatment modalities and to other disease areas in collaboration. Myeloid expects to enter the clinic with its two lead programs in the first half of 2021. The company, having operations in Cambridge, MA, was founded by Ronald Vale and Siddhartha Mukherjee.